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The	  airway	  delivery	  of	  genetic	  material	  inside	  the	  cell	  requires	  the	  design	  of	  vector	  nanoparticles	  
(NPs)	  showing	   low	  cytotoxicity,	  high	  efficiency	   in	  cellular	  absorption	  and	  ability	  to	  penetrate	  the	  
mucus	   barrier	   before	   releasing	  material	   to	   the	   nucleus.	   Polyamidoamines	   (PAAs)	   are	   promising	  
condensing	   structures	   for	   DNA	   and	   siRNA	   delivery,	   since	   they	   show	   good	   biocompatibility,	  
biodegradability	   and	   the	  ability	   to	   form	   stable	  polyplexes	  both	  with	  DNA	  and	  RNA	   strains	   [1,2].	  
Among	   these	   we	   exploited	   the	   potential	   of	   the	   4-­‐aminobutylguanidine-­‐deriving	   PAA	   named	  
AGMA1	   to	   transport	   siRNA	   and	   to	   target	   the	   enzyme	   β-­‐glucocerebrosidase	  GBA2	   from	   primary	  
Human	  Bronchial	   Epithelial	   cells	   (hBEC)	   of	   patients	   affected	   by	   Cystic	   Fibrosis	   (CF).	   CF	   patients’	  
mucus	  is	  a	  strong	  viscoelastic	  barrier	  leading	  to	  respiratory	  disease	  and	  high	  infection	  risk.	  We’re	  
testing	   lipid	   coating	   on	   AGMA1-­‐siRNA	   complexes	   as	   a	   possible	   strategy	   to	   cross	   the	   CF	  mucus	  
barrier.	  Transfection	  efficiency,	  cytotoxicity	  and	  siRNA	  efficacy	  have	  been	  investigated	  on	  primary	  
cellular	  cultures	   (ALI	  hBEC	  cultures).	  Besides,	   the	  structural	  properties	  of	   the	  nanoparticles	  have	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